Scales used for therapeutic trials in Alzheimer's disease
Vercelletto, M.
Revue Neurologique (Paris) 158(8-9): 857-861
2002
ISSN/ISBN: 0035-3787 PMID: 12386538 Document Number: 541875
Document emailed within 1 workday
Related Documents
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Andrieu, S.; Rascol, O.; Lang, T.; Grandjean, H.; Vellas, B. 2006: Disease modifying trials in Alzheimer disease: methodological and statistical issues Journal of Nutrition Health and Aging 10(2): 116-117
Peng, Y.; Li, P-ping.; Li, L.; Zhang, Y.; Hou, W-zhen.; Cui, D-dan.; Li, J.; Wang, L.; Wang, Q-li.; Wang, X-liang. 2016: Progress of clinical trials in Alzheimer's disease drugs Yao Xue Xue Bao 51(8): 1185-1195
Ferris, S.H.; Mackell, J.A. 1997: Behavioral outcomes in clinical trials for Alzheimer disease Alzheimer Disease and Associated Disorders 11(Suppl): S10-S15
Touchon, J.; Portet, F.; Gauthier, S. 2006: Prevention trials in Alzheimer disease: one step forward? Neurology 67(9 Suppl 3): S21-S22
Caban-Holt, A.; Bottiggi, K.; Schmitt, F.A. 2005: Measuring treatment response in Alzheimer's disease clinical trials Geriatrics Suppl: 3-8
Scheinin, N.M.; Scheinin, M.; Rinne, J.O. 2011: Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 55(3): 265-279
Vetel, J.M. 1993: Clinical trials in Alzheimer disease. Methodological problems: what application for what indication? Therapie 48(3): 207-210
Bullock, R.; Passmore, P.; Wilkinson, D.; Howard, R.; Jones, R. 2000: Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement Bmj 320(7233): 511-512
Davis, K.L. 1998: Future therapeutic approaches to Alzheimer's disease Journal of Clinical Psychiatry 59(Suppl): 14-16
Kellner, R.; Simpson, G.M.; Sheffield, B.F. 1977: The value of self-rating scales in drug trials Psychopharmacology Bulletin 13(2): 42-43
Iwatsubo, T. 2002: The mechanism of A beta production and its inhibition as a therapeutic strategy for the prevention of Alzheimer's disease Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 120(1): 30p-33p
Edwards, A L. 1966: A Comparison of 57 MMPI Scales and 57 Experimental Scales Matched with the MMPI Scales in Terms of Item Social Desirability Scale Values and Probabilities of Endorsement Educational and Psychological Measurement 26(1): 15-27
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11
Morris, J.C.; Mohs, R.C.; Rogers, H.; Fillenbaum, G.; Heyman, A. 1988: Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacology Bulletin 24(4): 641-652
Vamvakidès, A. 2003: Selective M1 muscarinic agonists: failure of therapeutic strategy against Alzheimer's disease or inappropriate tactics? Annales Pharmaceutiques Francaises 61(3): 207-210
Tatebayashi, Y. 2003: The dentate gyrus neurogenesis: a common therapeutic target for Alzheimer disease and senile depression? Seishin Shinkeigaku Zasshi 105(4): 398-404
Miyakawa, T. 1988: Brain pathology in Alzheimer's disease. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1471-1474